Roche Holding Ltd header image

Roche Holding Ltd

ROG

Equity

ISIN CH0012032048 / Valor 1203204

SIX Swiss Exchange (2026-10-26)
CHF 396.50+1.43%

Roche Holding Ltd
UMushroom community rating:

star star star star star
4.30 50 votes No rating yet
NegativeNeutralPositive

About company

Roche Holding Ltd is a Swiss multinational healthcare company headquartered in Basel that operates primarily through two businesses: Pharmaceuticals and Diagnostics. The Pharmaceuticals division develops and commercializes prescription medicines—particularly biologics and targeted therapies—across oncology, immunology, infectious diseases, neuroscience and ophthalmology, and includes the majority-owned US biotech unit Genentech; several well-known oncology drugs in its portfolio have driven its commercial profile. The Diagnostics division supplies laboratory and point-of-care instruments, reagents and software for clinical chemistry, molecular diagnostics, tissue-based cancer testing and diabetes care (including blood‑glucose systems), serving hospitals, clinical labs and blood‑screening organizations worldwide. Roche is research-intensive, invests heavily in R&D and in partnerships or acquisitions with other biotech firms to advance targeted and personalized medicine, and is publicly listed with a broad global commercialization and distribution footprint.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

46.2%1Y
67.1%3Y
10.8%5Y

Performance

24.8%1Y
22.3%3Y
21.0%5Y

Volatility

Market cap

330370 M

Market cap (USD)

Daily traded volume (Shares)

1,347,002

Daily traded volume (Shares)

1 day high/low

253.6 / 250.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.30

50 votes
Performance:
starstarstarstarstar
4.06
Innovation:
starstarstarstarstar
4.32
Society:
starstarstarstarstar
4.15
Nature:
starstarstarstarstar
3.74
Yuki Nakamitsu
UK, 20 Oct 2026
star star star star star
Roche Holding Ltd represents a defensive pharmaceutical cornerstone with robust cash flows and a leading oncology pipeline. Exceptional pricing power and disciplined R&D investment ensure strong margins, while defensive resilience provides an ideal hedge against macro volatility.
Yash Desai
UK, 19 Oct 2026
star star star star star
Good returns in a pharmaceutical industry that has consistently performed well
Sandra Kappeler
Switzerland, 04 Oct 2026
star star star star star
.

EQUITIES OF THE SAME SECTOR

Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%USD 58.23
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.88%USD 205.70
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 90.34
Herbalife Ltd
Herbalife Ltd Herbalife Ltd Valor: 2002103
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%USD 13.28
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.23%USD 9.22
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 31.34
MedNation AG
MedNation AG MedNation AG Valor: 331107
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%EUR 3.96
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 70.05
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%USD 13.77
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 43.42